Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients with Advanced Cirrhosis or Post‐transplant Recurrence: Final Results of the ALLY‐1 Study: 2016 ACG Presidential Poster Award: 774. (October 2016) - Poordad, Fred; Schiff, Eugene; Vierling, John M.; Landis, Charles; Fontana, Robert J.; Yang, Rong; McPhee, Fiona; Noviello, Stephanie; Swenson, Eugene S.